[HTML][HTML] Model-informed precision dosing: State of the art and future perspectives

IK Minichmayr, E Dreesen, M Centanni, Z Wang… - Advanced drug delivery …, 2024 - Elsevier
Abstract Model-informed precision dosing (MIPD) stands as a significant development in
personalized medicine to tailor drug dosing to individual patient characteristics. MIPD moves …

Long-term immunosuppression management: opportunities and uncertainties

D Wojciechowski, A Wiseman - … Journal of the American Society of …, 2021 - journals.lww.com
The long-term management of maintenance immunosuppression in kidney transplant
recipients remains complex. The vast majority of patients are treated with the calcineurin …

Sirolimus and secondary skin-cancer prevention in kidney transplantation

S Euvrard, E Morelon, L Rostaing… - … England Journal of …, 2012 - Mass Medical Soc
Background Transplant recipients in whom cutaneous squamous-cell carcinomas develop
are at high risk for multiple subsequent skin cancers. Whether sirolimus is useful in the …

Renal association clinical practice guideline in post-operative care in the kidney transplant recipient

RJ Baker, PB Mark, RK Patel, KK Stevens, N Palmer - BMC nephrology, 2017 - Springer
These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy …

J Nelson, N Alvey, L Bowman, J Schulte… - … : The Journal of …, 2022 - Wiley Online Library
Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation

LS Nguyen, M Vautier, Y Allenbach, N Zahr… - Drug safety, 2019 - Springer
Inhibitors of mechanistic target of rapamycin (mTOR inhibitors) are used as antiproliferative
immunosuppressive drugs and have many clinical applications in various drug …

The translational machinery of human CD4+ T cells is poised for activation and controls the switch from quiescence to metabolic remodeling

S Ricciardi, N Manfrini, R Alfieri, P Calamita, MC Crosti… - Cell metabolism, 2018 - cell.com
Naive T cells respond to T cell receptor (TCR) activation by leaving quiescence, remodeling
metabolism, initiating expansion, and differentiating toward effector T cells. The molecular …

Roles of mTOR complexes in the kidney: implications for renal disease and transplantation

D Fantus, NM Rogers, F Grahammer… - Nature Reviews …, 2016 - nature.com
The mTOR pathway has a central role in the regulation of cell metabolism, growth and
proliferation. Studies involving selective gene targeting of mTOR complexes (mTORC1 and …

[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …

M Reinwald, JT Silva, NJ Mueller, J Fortún… - Clinical Microbiology …, 2018 - Elsevier
Background The present review is part of the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH) …

Predicting clinical events by combining static and dynamic information using recurrent neural networks

C Esteban, O Staeck, S Baier, Y Yang… - 2016 IEEE …, 2016 - ieeexplore.ieee.org
In clinical data sets we often find static information (eg patient gender, blood type, etc.)
combined with sequences of data that are recorded during multiple hospital visits (eg …